Skip to Content
Merck
  • Relative androgenicity, blood pressure levels, and cardiovascular risk factors in young healthy women.

Relative androgenicity, blood pressure levels, and cardiovascular risk factors in young healthy women.

American journal of hypertension (1995-06-01)
C S Mantzoros, E I Georgiadis, R Young, C Evagelopoulou, S Khoury, N Katsilambros, J R Sowers
ABSTRACT

To test the hypothesis that androgens may play a role in the pathogenesis of atherosclerosis and hypertension, we investigated the association of delta 5 dehydroepiandrosterone sulfate [DHEAS]) and delta 4 (free testosterone [FT]) androgens with the resting, seated blood pressure (BP) levels and cardiovascular risk factors in 280 young, healthy women 18 to 24 years of age. After application of multiple regression analysis, systolic BP was positively and independently correlated with the ratio of dehydroepiandrosterone sulfate to free testosterone (DHEAS/FT), fasting insulin levels, and the diastolic BP with DHEAS/FT only. The DHEAS/FT ratio proved to be a stronger predictor of the BP levels than either hormone alone. Further, uric acid concentrations and HDL/total cholesterol ratio were independently correlated with both FT and body mass index in these young women. Serum triglycerides were independently correlated with FT and central body fat distribution. These data suggest that serum androgen concentrations are important independent predictors of cardiovascular risk factors and that the ratio of dehydroepiandrosterone sulfate to free testosterone ratio is an independent predictor of blood pressure levels in young women.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Dehydroacetic acid sodium salt monohydrate, Arxada quality, 98.0-101.0 % (w/w) (T)
Sigma-Aldrich
Dehydroacetic acid sodium salt, Arxada quality, 99.0-100.3 % (w/w) (T)
Sigma-Aldrich
Dehydroacetic acid, ≥98.0% (T)